The global pandemic of Coronavirus Disease 2019 (COVID-19) has brought the world to a
grinding halt. A major cause of concern is the respiratory distress associated mortality …

The emergence of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) not only affects the
respiratory tract but also causes neurological symptoms such as loss of smell and taste …

In this study, we report a one-pot, green, cost-efficient, and fast synthesis of plant-based
sulfur and nitrogen self-co-doped carbon quantum dots (S, N-CQDs). By 4-min microwave …

Background The absence of specific antivirals to treat COVID-19 leads to the repositioning
of candidates' drugs. Nitazoxanide (NTZ) has a broad antiviral effect. Methods This was a …

In this era, broad‐spectrum prodrugs with anti‐severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) activities are gaining considerable attention owing to their …

Antiviral drug development for coronavirus disease 2019 (COVID-19) is occurring at an
unprecedented pace, yet there are still limited therapeutic options for treating this disease …

The rapidly growing COVID-19 pandemic is the most serious global health crisis since the
“Spanish flu” of 1918. There is currently no proven effective drug treatment or prophylaxis for …

The spread of new coronavirus infection starting December 2019 as novel SARS-CoV-2,
identified as the causing agent of COVID-19, has affected all over the world and been …

Background This exploratory study investigated four repurposed anti-infective drug
regimens in outpatients with COVID-19. Methods This phase 2, single centre, randomised …